Amedisys, Inc. (NASDAQ:AMED) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been assigned an average rating of “Hold” from the five analysts that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price […]

Apr 21, 2025 - 07:51

Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been assigned an average rating of “Hold” from the five analysts that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price […]